MYC and non-small cell lung carcinoma: c-Myc over-expression in the absence of gene amplification is also observed in about 50% of non-small cell lung cancer (NSCLC) as evidenced by immunohistochemistry of different types of NSCLC (http://www.proteinatlas.org and [8]).